Characterization Complex Involved In Rothmund-Thomson
Characterization Complex Involved In Rothmund-Thomson
批准号:
7132306
负责人:
Weidong Wang
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rothmund Thomson Syndrome (RTS) is a rare disease associated with genome instability, predisposition to cancer, skin and skeletal abnormalities, and some features of premature aging. The disease is caused by mutation in RECQL4, a putative helicase of the RecQ family which includes WRN and BLM, proteins defective in Werner and Bloom syndromes, respectively. To understand the mechanism of this disease, we have purified a human RECQL4 complex and identified its associated components. We found that the bulk of RECQL4 was present in a cytoplasmic extract of HeLa cells, in contrast to the largely nuclear BLM and WRN helicases. However, in untransformed WI-38 fibroblasts, RECQL4 was found to be largely nuclear, and was present at significantly lower total levels than in transformed HeLa cells. RECQL4 from HeLa cells was isolated as a stable complex with UBR1 and UBR2. These 200 kD proteins are ubiquitin ligases of the N-end rule pathway, whose substrates include proteins with destabilizing N-terminal residues. The functions of this proteolytic pathway include the regulation of peptide import, chromosome stability, meiosis, apoptosis, and cardiovascular development. Although the known role of UBR1 and UBR2 is to mediate polyubiquitylation (and subsequent degradation) of their substrates, the UBR1/2-bound RECQL4 was not ubiquitylated in vivo, and was a long-lived protein in HeLa cells. The isolated RECQL4-UBR1/2 complex had a DNA-stimulated ATPase activity but was inactive in DNA-based assays for helicases and translocases, the assays in which the BLM helicase was active. Our data suggest that RECQL4 and ubiquitin ligases of the N-end rule pathway may play a role in maintaining genomic stability. The first report of these studies is now published in Human Molecular Genetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment
-
批准号:10529960
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2022
-
负责人:Weidong Wang
-
依托单位:
Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment
-
批准号:10665748
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2022
-
负责人:Weidong Wang
-
依托单位:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
-
批准号:10580851
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2021
-
负责人:Weidong Wang
-
依托单位:
Cytoprotection and the mechanism of action of a natural product Khellin against ER stress
-
批准号:9974514
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2018
-
负责人:Weidong Wang
-
依托单位:
Cytoprotection and the mechanism of action of a natural product Khellin against ER stress
-
批准号:10285537
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2018
-
负责人:Weidong Wang
-
依托单位:
Preclinical Development of Khellin Analogs for Anti-Diabetic Therapy
-
批准号:9336063
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2016
-
负责人:Weidong Wang
-
依托单位:
Preclinical Development of Khellin Analogs for Anti-Diabetic Therapy
-
批准号:9353780
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2016
-
负责人:Weidong Wang
-
依托单位:
Structural And Functional Studies Of Human Swi/snf Chromatin-remodeling
-
批准号:10467892
-
项目类别:
-
资助金额:$127.74万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease
-
批准号:10469229
-
项目类别:
-
资助金额:$21.36万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification and Characterization of human Rsc Chromatin-Remodeling Complex
-
批准号:6431445
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification Of A Complex Involved In Bloom Syndrome
-
批准号:6668115
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification And Characterization Of Human Rsc Chromat
-
批准号:6668110
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification/characterization Complex-Bloom Syndrome
-
批准号:7132305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
A Multiprotein Complex Involved In Atrx Syndrome
-
批准号:6969367
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Derivation of pancreatic beta cells from human induced pluripotent stem cells
-
批准号:8466516
-
项目类别:
-
资助金额:$34.44万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigation of an RNA topoisomerase complex involved in Fragile X syndrome
-
批准号:8931567
-
项目类别:
-
资助金额:$64.26万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Characterization of a Complex Involved In Rothmund-Thomson Syndrome
-
批准号:8335886
-
项目类别:
-
资助金额:$38.55万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigating roles of Topoisomerase 3b (TOP3B) in immune responses to infection by coronavirus and bacteria
-
批准号:10913087
-
项目类别:
-
资助金额:$37.57万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigating the roles of RNA-binding proteins Nocte and PRRC2 in mRNA translation and age-related neurodegeneration using Drosophila and mouse models
-
批准号:10913081
-
项目类别:
-
资助金额:$21.47万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification Of A Complex Involved In Werner Syndrome
-
批准号:6815266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
海外基金